2018 PDA Biosimilars Workshop

2018 PDA Biosimilars Workshop

Getting it Right the First Time for Biosimilar Marketing Applications

Over two days, noted industry experts and speakers from the U.S. FDA, EMA, Health Canada, and the Medicines Evaluation Board (MEB) in The Netherlands will share the most common challenges they’ve identified in biosimilar applications, both in established requirements and in more progressive areas, such as statistical tools. Gain practical approaches to tackle technical obstacles and avoid the pitfalls frequently encountered during biosimilar candidate development!

Leave a Comment

Your feedback is valuable for us. Your email will not be published.

Please wait...

Please leave these two fields as-is:
2018 PDA Biosimilars Workshop